
    Original Text: Any concurrent active malignancies, defined as malignancies requiring any therapy other than expectant observation, because adverse events (AEs) resulting from these malignancies or their treatment may confound our assessment of the safety of adoptive T-cell therapy for ovarian cancer
    Disease/Condition: Concurrent Active Malignancy, Active Malignancy
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: MALIGNANCY == True, ACTIVE == True

Criterion:
    Patients with a history of prior chemotherapy within 4 weeks before enrollment

Output:
    Original Text: Patients with a history of prior chemotherapy within 4 weeks before enrollment
    Disease/Condition: Prior Chemotherapy, Chemotherapy
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: CHEMOTHERAPY == True

Criterion:
    Patients with a history of prior radiation therapy within 4 weeks before enroll